Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
Editorial summary Inhibitors of read more poly(ADP-ribose) polymerase (PARPi) have entered the clinic for the treatment of patients with cancers that lack homology-directed DNA repair, but drug resistance remains a clinical hurdle.Recent advances in the identification of PARPi resistance mechanisms have yielded a better understanding of DNA end pro